ETTX

Entasis Therapeutics Holdings Inc. ETTX

Trading inactive

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode ETTX HLVX JNCE CYT RVLP OPNT TRML PRTK AADI DBTX
6M 0.00 % 23.67 % 109.45 % -1.63 % -96.93 % 92.09 % 184.07 % -1.76 % -4.65 % 82.53 %
YTD 0.00 % 0.48 % 72.48 % 0.00 % -97.55 % 2.03 % 132.46 % 19.89 % -34.71 % 136.63 %
1Y 23.03 % 11.76 % -49.19 % 55.68 % -98.08 % -3.59 % 80.44 % -26.64 % 12.64 % 22.14 %
3Y -56.20 % -87.39 % -65.94 % -82.64 % -99.54 % 115.55 % 199.88 % -54.12 % -86.82 % -72.77 %
5Y -79.46 % -89.05 % -74.83 % -82.64 % -99.60 % 8.68 % -70.47 % -75.19 % -76.30 % -72.77 %
10Y -79.46 % -89.05 % -89.10 % -82.64 % -99.65 % 41 200.00 % -70.47 % -91.08 % -97.72 % -72.77 %
From the beginning -79.46 % -89.05 % -89.10 % -82.64 % -99.65 % -63.55 % -70.47 % -95.11 % -97.72 % -72.77 %

Dividend

Cyteir Therapeutics, Inc.

Tourmaline Bio, Inc.

Paratek Pharmaceuticals, Inc.